2025--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) has been named the 2024 North America IPO of the Year by International Financing Review (IFR) in the publication’s prestigious annual ...

Viking® (www.viking.com) (NYSE: VIK) has been named the 2024 North America IPO of the Year by International Financing Review (IFR) in the publication’s prestigious annual awards. The honor ...

ProShares, the world’s largest issuer of leveraged and inverse funds, and Nasdaq are joining together ... rings the Closing Bell. Sign up for our newsletter to get the latest on the ...

Novocure (Nasdaq: NVCR), a global oncology company working ... In honor of the occasion, Ashley Cordova, CEO, rings the Opening Bell. Sign up for our newsletter to get the latest on the ...

Viking is continuing to invest in its fleet, aided by expected industry growth in the next few years. Read more to see ...

VKTX opened at $32.56 on Thursday. The company has a market cap of $3.63 billion, a PE ratio of -35.01 and a beta of 0.90. Viking Therapeutics has a twelve month low of $25.34 and a twelve month ...

Viking Therapeutics (NASDAQ:VKTX – Free Report) had its target price lowered by Maxim Group from $120.00 to $70.00 in a research note issued to investors on Friday morning,Benzinga reports.

SuitUp visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Zach Graumann, Co-Founder and Chairman of the Board, rings the Closing Bell. Sign up for our newsletter to get the ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) gapped down before the market opened on Thursday following a dissappointing earnings announcement. The stock had previously closed at $ ...

For the third time, the City of Tyler Police Department won against local first responders in Salvation Army’s annual First Responders Ringing of the Bell Challenge. The City of Tyler Police ...

Nearly a year ago, Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results from a clinical trial with an experimental weight loss ...